Brawn Nutrition TB-500 50mcg 60 Caps

Description

Brawn Nutrition TB-500 50mcg 60 Caps is a specialist single-compound capsule product containing a declared 500 mcg of TB-500 per capsule.

Each container provides 60 capsules. Available retailer information identifies the compound as the 17–23 fragment of thymosin beta-4. The physical product label should remain the primary source for the final composition, capsule shell, excipients, batch details and storage information.

What is TB-500?

TB-500 is an experimental synthetic peptide associated with thymosin beta-4 research. More precisely, FDA documentation identifies TB-500 as the thymosin beta-4 fragment LKKTETQ, rather than the complete naturally occurring thymosin beta-4 protein. It is not a SARM, anabolic steroid, vitamin or conventional nutritional ingredient.

Laboratory and preclinical research has examined thymosin beta-4–related compounds in connection with cell migration, actin regulation, angiogenesis and tissue-repair processes. These areas of research do not establish clinically proven regenerative, injury-healing or anti-inflammatory effects for this commercial oral capsule product.

Product specifications

• Brand: Brawn Nutrition
• Product name: TB-500
• Declared compound: TB-500
• Declared amount: 500 mcg per capsule
• Package size: 60 capsules
• Product form: capsules
• Compound category: experimental synthetic peptide
• Related designation: thymosin beta-4 fragment 17–23

Before publication or dispatch, verify the declared amount, complete ingredient list, capsule count, batch number, expiry date, storage conditions and warnings against the original bottle.

Product presentation and verification

A complete catalogue listing should allow customers to verify:

• the Brawn Nutrition branding,
• the TB-500 product name,
• the declared 500 mcg specification,
• the 60-capsule package size,
• the complete quantitative ingredient panel,
• the batch and expiry information,
• the manufacturer or responsible operator,
• the condition of the original safety seal.

A container should not be distributed when the seal is damaged, the label appears altered or the physical specifications differ from the online description.

Responsible catalogue information

TB-500 products are frequently promoted using claims concerning injury recovery, tendon or ligament repair, wound healing, inflammation and muscle regeneration. Such statements should not be presented as guaranteed, medically approved or clinically established effects of this particular commercial product.

FDA states that it has not identified human-exposure data for drug products containing the thymosin beta-4 fragment known as TB-500. It also identifies potential concerns involving immunogenicity, aggregation and peptide-related impurities and states that important human-safety information is lacking.

The capsule format or supplement-style presentation does not demonstrate regulatory approval, purity, bioavailability, safety or effectiveness.

Information for tested athletes

Thymosin beta-4 and its derivatives, including TB-500, are listed in section S2.3 of the 2026 WADA Prohibited List. They are prohibited at all times, both in and out of competition.

This description is provided solely for product identification and catalogue-reference purposes. It does not contain dosing instructions, treatment recommendations, medical advice or guarantees of regenerative effects.